Recent research reveals that weight loss medications are significantly altering consumer spending behavior in Australia. More than 400,000 Australians are currently using Glucagon-Like Peptide-1...
The World Health Organization (WHO) has released its inaugural guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies in treating obesity, a condition that...